3-Phenoxybenzaldehyde

CAS No. 39515-51-0

3-Phenoxybenzaldehyde( —— )

Catalog No. M35820 CAS No. 39515-51-0

3-Phenoxybenzaldehyde is a complement (classical pathway) inhibitor with IC50 of 1388μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-Phenoxybenzaldehyde
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Phenoxybenzaldehyde is a complement (classical pathway) inhibitor with IC50 of 1388μM.
  • Description
    3-Phenoxybenzaldehyde has weak complement classical pathway inhibition and hemolytic activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Complement System
  • Recptor
    Complement System
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    39515-51-0
  • Formula Weight
    198.22
  • Molecular Formula
    C13H10O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (504.49 mM; Ultrasonic )
  • SMILES
    O=CC1=CC=CC(OC2=CC=CC=C2)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Master HE, et al. Synthesis of low molecular weight compounds with complement inhibition activity. Bioorg Med Chem Lett. 2003 Apr 7;13(7):1249-51.?
molnova catalog
related products
  • Avacopan

    Avacopan (CCX-168, CCX168) is a potent, selective, orally availale C5aR (CD88) inhibitor with IC50 of 0.1 nM.

  • ADH-503

    ADH-503 is a potent agonist of the integrin CD11b to mitigate myeloid cell immunosuppression.

  • Vesencumab

    Vesencumab (MNRP-1685A) is an IG1 antibody targeting NRP-1 with anti-angiogenic and anti-tumor activity that reduces the number of globules formed by the SUM159 and Hs578T cell lines. Vesencumab inhibits EGFR and PDGFRα activation and can be used to study solid tumors.